ALIM
Alimera Sciences Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $2.52
- Day High
- $2.65
- Day Low
- $2.51
- Day Open
- $2.65
- Volume
- 313
- Day Change
- -6.35%
Latest news data for ALIM
Age-related macular degeneration (AMD) market size to increase by USD 4,360.68 million: Evolving Opportunities with Amgen Inc and Apellis Pharmaceuticals Inc among others - Technavio
prnewswire.com
Age-Related Macular Degeneration (AMD) Global Market Report 2022: Sector to Reach $14.6 Billion by 2028 at an 8.5% CAGR
prnewswire.com
Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd
globenewswire.com
Alimera Sciences Announces Agreement to Extend Amortization Date and Interest-Only Period on Loan Agreement
globenewswire.com
Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 10.74% by 2032: Visiongain Reports Ltd
globenewswire.com
The Worldwide Diabetic Retinopathy Industry is Expected to Reach $7.7 Billion by 2027 at a 11.3% CAGR
prnewswire.com
Alimera Sciences, Inc. (ALIM) Q3 2022 Earnings Call Transcript
seekingalpha.com
Age-Related Macular Degeneration Market Size Worth USD 14.98 Billion by 2030 at 8.1% CAGR – Report by Market Research Future (MRFR)
globenewswire.com
Alimera Sciences GAAP EPS of -$0.75 misses by $0.35, revenue of $13.6M misses by $1.45M (NASDAQ:ALIM)
seekingalpha.com
Global Diabetic Retinopathy Market Report 2022: Escalating Diabetes Related Complications Fuel Sector Growth
prnewswire.com